Skip to main content

Peer Review reports

From: Acceptance of oclacitinib maleate (Apoquel®) chewable tablets in client-owned dogs with allergic and atopic dermatitis

Original Submission
15 Dec 2021 Submitted Original manuscript
10 Jan 2022 Reviewed Reviewer Report
10 Jan 2022 Reviewed Reviewer Report
1 Feb 2022 Author responded Author comments - Marike Visser
Resubmission - Version 2
1 Feb 2022 Submitted Manuscript version 2
14 Feb 2022 Author responded Author comments - Marike Visser
Resubmission - Version 3
14 Feb 2022 Submitted Manuscript version 3
16 Feb 2022 Author responded Author comments - Marike Visser
Resubmission - Version 4
16 Feb 2022 Submitted Manuscript version 4
28 Feb 2022 Reviewed Reviewer Report
3 Mar 2022 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
7 Mar 2022 Editorially accepted
17 Mar 2022 Article published 10.1186/s12917-022-03210-x

You can find further information about peer review here.

Back to article page